Diagnostic Performance of PET Imaging Using Different Radiopharmaceuticals in Prostate Cancer According to Published Meta-Analyses
Martedì 4 agosto 2020
circa 1 minuti di lettura
Journal and Affiliations:
Cancers, 4 agosto 2020
Giorgio Treglia, Clinica di Medicina nucleare, Istituto di Imaging della Svizzera italiana, EOC, Bellinzona e Academic Education, Research and Innovation Area, EOC, Bellinzona
Tags:
choline
evidence-based
imaging
meta-analysis
nuclear medicine
PET
prostate
PSMA
Authors:
Giorgio Treglia